Cytox (AgeTech UK) NeuroTech
Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway.
Connections from
Investor Type:
N/A
Technology:
AgeTech Companies
Investment Stage:
N/A
Founded Date:
N/A
Industry:
UK AgeTech 2020
Employee Number:
N/A
Funding Status:
N/A
Number Of Exists:
N/A
Headquarters:
United Kingdom